BMJ 2007;334:925 (5 May), doi:10.1136/bmj.39202.413912.DB
News
Medicare proposes to expand payments to encourage trials of effectiveness
Janice Hopkins Tanne
New York
| The first 150 words of the full text of this article appear below. |
The US Centers for Medicare and Medicaid Services, which runs the federal Medicare health insurance plan for elderly people, last month proposed changes to how it pays for clinical trials.
If accepted, the changes would help Medicare compare existing treatments and make scientific and payment decisions that could save money while still providing effective treatment.
Under the current policy, developed in 2000, Medicare pays for certain items and services and for healthcare costs of Medicare beneficiaries who are taking part in clinical trials, but it does not pay for the "investigational" drugs, tests, and devices used in trials even when these drugs, tests, and devices have already been approved by the Food and Drug Administration (FDA). If people were receiving the FDA approved drug, test, or device outside the clinical trial, Medicare would pay for it.
Under the proposed policy Medicare would cover the cost of drugs, devices, and tests
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article
- Full text
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Find similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Related content
Bookmark with
What's new
BMJ video
Resources
Tools
Online poll
Find out more
Services
Rapid responses for this article
There are no rapid responses for this article.Most read last week
Print issues
Student BMJ
Risk of surgery for inflammatory bowel disease: record linkage studies
What can you learn from this BMJ paper? Read Leanne Tite's Paper+
